Form 4: Imunon Inc. Insider Trades: Lindborg Acquires Stock

Stacy Lindborg, President and CEO of Imunon, Inc., acquired 1,593 shares of common stock on June 5, 2026, valued at $2.06 per share, as part of a stock grant in lieu of cash for salary.

Summary

• Stacy Lindborg, President and CEO and Director of Imunon, Inc., acquired 1,593 shares of common stock on June 5, 2026.
• The acquisition was made at a price of $2.06 per share.
• These shares were granted in lieu of cash for a portion of her base salary.
• Following this transaction, Lindborg beneficially owns 5,235 shares of common stock, with 778 shares held indirectly through a 401(k) plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents an insider acquiring stock, which can signal confidence, but it is part of a compensation arrangement rather than an open market purchase.

Positives

• Insider acquisition of stock by a key executive (President and CEO) can signal confidence in the company's future prospects.
• The transaction indicates a portion of executive compensation is being tied to equity, aligning management interests with shareholders.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider stock acquisitions, particularly by senior management, are often viewed positively by the market as they can indicate a belief in the company's intrinsic value and future growth potential. This type of transaction is common in the biotechnology and pharmaceutical sectors where executive compensation packages frequently include equity components.

Stakeholder Impact

• Shareholders: The acquisition by a key executive may be interpreted as a positive signal of management's commitment and belief in the company's value.
• Employees: This transaction highlights a compensation strategy that can align executive interests with those of shareholders.
• Management: Stacy Lindborg's compensation is partially tied to the company's equity.

Key Dates

Keywords

Imunon Inc., IMNN, Form 4, Insider Trading, Stock Acquisition, Executive Compensation, Stacy Lindborg, SEC Filing